EXPLOITING DNA DAMAGE RESPONSE PATHWAY: DEVELOPMENT OF PTK6 INHIBITOR FOR TREATMENT OF OVARIAN CANCER
Master's
Saved in:
Main Author: | ANG HUI LI |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/211897 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
TARGETING THE WNT PATHWAY IN OVARIAN CANCER DISSEMINATION
by: WONG MENG KANG
Published: (2015) -
DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
by: SHAIKH MOHAMMED ISHAQUE
Published: (2012) -
Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer
by: Huang, R.Y.-J., et al.
Published: (2014) -
RUNX3 functions as an oncogene in ovarian cancer
by: Lee, C.W.L., et al.
Published: (2014) -
The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
by: Yamamura, S., et al.
Published: (2014)